Previous 10 | Next 10 |
BETHLEHEM, Pa., May 29, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced that it has entered into a defini...
BETHLEHEM, Pa., May 26, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, Ph.D., President and CEO, will...
Navidea Biopharmaceuticals (NYSEMKT: NAVB ) +161% on positive Tc99m tilmanocept data in rheumatoid arthritis. More news on: Navidea Biopharmaceuticals, Inc., Medigus Ltd., Digirad Corporation, Stocks on the move, , Read more ...
OraSure Technologies (NASDAQ: OSUR ) announced that its OMNIgene ORAL saliva collection device (OM-505) was included in FDA Emergency Use Authorization (EUA) granted to P23 Labs. More news on: OraSure Technologies, Inc., Healthcare stocks news, Stocks on the move, Read more ...
OTTAWA, May 22, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, (NASDAQ: OSUR), announced today that its OMNIgene®·ORAL saliva collection...
ST. PAUL, Minn. and OAKLAND, Calif., May 22, 2020 (GLOBE NEWSWIRE) -- Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), and Nom Nom™, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
BETHLEHEM, Pa., May 15, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Virtual Glob...
BETHLEHEM, Pa., May 14, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2020 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 19, 2020. In or...
All Microbiome Services to be Unified under the Diversigen Brand BETHLEHEM, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, to...
News, Short Squeeze, Breakout and More Instantly...
OraSure Technologies Inc. Company Name:
OSUR Stock Symbol:
NASDAQ Market:
OraSure Technologies Inc. Website:
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024. A webcast of the conference call w...
2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $4.50 for OSUR on 2024-07-02 08:07:00. The adjusted price target was set to $4.50. At the time of the announcement, OSUR was trading at $4.27. OSUR currently trades -49.59% versus its 52 week h...
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Tes...